Healthtech & Biotech
Follow the companies advancing digital health, diagnostics, drug discovery, and biotech platforms across APAC.
Live snapshot
Why this channel matters
Regulatory approvals and clinical milestones in APAC markets often surface through local-language official channels first.
Partnership and licensing signals between biotech companies cluster earlier here than in English-language industry reports.
This channel is useful for tracking both established pharma companies and emerging biotech challengers.
Key questions this channel answers
These are the types of strategic questions you can answer by monitoring this channel.
Which biotech companies are reaching clinical milestones or regulatory approvals?
What digital health partnerships and platform expansions are forming?
Where is drug discovery and diagnostics innovation concentrating in APAC?
Strategic themes
This channel covers 6 strategic themes. Each theme represents a distinct area of company activity monitored through official sources.
Top companies
View all rankingsSource Language Coverage
Recent signals
View allZuellig Pharma Launches Mounjaro in Thailand for Obesity and Diabetes
Roche's breast cancer drug giredestrant fails to meet primary endpoint in Phase III persevERA trial, impacting oncology pipeline and future market position.
Roche's Breast Cancer Drug Fails to Meet Main Goal in Phase III Trial
Yuhan Corporation's lung cancer drug 'Leclaza' gains approval for German health insurance, enhancing European market access and potential revenue.
Yuhan Corporation's Lung Cancer Drug 'Leclaza' Approved for German Health Insurance
Canada Contracts CSL Seqirus for Pandemic Influenza Vaccines
Canada and CSL Seqirus Agree on New Pandemic Preparedness Contract
WuXi AppTec Explores Saudi Arabia CRDMO Expansion via MoUs
WuXi AppTec Explores Saudi Arabia Expansion via MoUs with NEOM and Ministry of Health
Docquity and Novartis Partner on Retinal Health in Malaysia
How professionals use this channel
Competitive monitoring
Track clinical milestones, regulatory approvals, and competitive moves across healthtech players.
Sector mapping
Build a structured view of the healthtech landscape across diagnostics, drug discovery, and digital health.
Investor tracking
Monitor funding rounds, licensing deals, and strategic investment patterns in the healthtech ecosystem.
Start monitoring Healthtech & Biotech
Get structured intelligence from official sources across languages — before it reaches the English web.